Hims & Hers Health Inc has forecast 2026 revenue that will meet Wall Street’s expectations, provided that it can continue selling copycat weight loss drugs that are mired in legal and regulatory risks. Read full story
Date: 25 February, 2026 6:00 am
Source: thestar.com.my
💬 Join the Conversation! 💬
We’ve disabled comments on our posts and pages to keep the discussions organized and lively! But don’t worry – the conversation isn’t over. Head over to our forum and share your thoughts, ideas, and feedback with the community! It’s the perfect place to connect, learn, and engage with others who care about the same things. We can’t wait to hear from you!